05:25 PM EDT, 10/02/2024 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) after trade Wednesday detailed the recent appointments of Chief Scientific Officer Amanda Malone as Chief Operating and Scientific Officer, and Rahul Sarugaser as Executive Vice President of Corporate Development.

Malone co-founded Eupraxia in 2012 and built Eupraxia's research, manufacturing, quality, non-clinical, regulatory, intellectual property and clinical functions.

Over the past 20 years, Sarugaser has held progressively senior roles in the capital markets and healthcare sector, and was most recently Managing Director, Equity Research, Biotech & Medtech with Raymond James, where he actively covered Eupraxia.

The company's shares closed up $0.01 to $3.51 on the Toronto Stock Exchange.